Effects of antenatal glucocorticoids on the developing brain
- PMID: 27343976
- PMCID: PMC5052110
- DOI: 10.1016/j.steroids.2016.05.012
Effects of antenatal glucocorticoids on the developing brain
Abstract
Glucocorticoids (GCs) regulate distinct physiological processes in the developing fetus, in particular accelerating organ maturation that enables the fetus to survive outside the womb. In preterm birth, the developing fetus does not receive sufficient exposure to endogenous GCs in utero for proper organ development predisposing the neonate to complications including intraventricular hemorrhage, respiratory distress syndrome (RDS) and necrotizing enterocolitis (NEC). Synthetic GCs (sGCs) have proven useful in the prevention of these complications since they are able to promote the rapid maturation of underdeveloped organs present in the fetus. While these drugs have proven to be clinically effective in the prevention of IVH, RDS and NEC, they may also trigger adverse developmental side effects. This review will examine the current clinical use of antenatal sGC therapy in preterm birth, their placental metabolism, and their effects on the developing brain.
Keywords: Antenatal; Glucocorticoids; Neurodevelopment; Preterm birth.
Published by Elsevier Inc.
Figures


References
-
- Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth (Review). Cochrane Libr. 2013 doi:10.1002/14651858.CD004454.pub2.Copyright. - PubMed
-
- Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 1: Outcomes. Nat. Rev. Endocrinol. 2014;10:391–402. - PubMed
-
- Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 2: mechanisms. Nat. Rev. Endocrinol. 2014;10:403–11. - PubMed
-
- Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database Syst. Rev. 2013;8:CD006764. - PubMed
-
- Khulan B, Drake AJ. Glucocorticoids as mediators of developmental programming effects. Best Pract. Res. Clin. Endocrinol. Metab. 2012;26:689–700. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical